SHOGUN Semaglutide (Ozempic) 5mg
Alias: Ozempic / Wegovy / GLP-1
Category: Peptide Hormone / GLP-1 Receptor Agonist
Half-Life: ~7 days
Molecular Weight: ~4113 Da
Typical Dosage:
Fat Loss: 0.25-1.0mg per week (titrated up)
Therapeutic Range (FDA Approved): Up to 2.4mg/week (Wegovy)
Reconstitution: Mix with BAC water (if in lyophilized form)
Administration: Subcutaneous injection (1x per week)
Storage: Refrigerated after reconstitution or opening
Semaglutide is a GLP-1 receptor agonist, originally developed to treat type 2 diabetes under the name Ozempic, and later FDA-approved for medical weight loss as Wegovy. Its primary mechanism? Mimicking the natural hormone GLP-1, which slows gastric emptying, reduces appetite, and regulates blood sugar levels.
In the performance world, Semaglutide has quickly become a cutting-edge fat-loss agent-helping users drastically reduce calorie intake, control cravings, and drop body fat without stimulants or crash diets.
How It Works
Semaglutide binds to GLP-1 receptors, triggering:
Slower gastric emptying →
Keeps you full longer.
Appetite suppression → Reduced hunger and portion size.
Reviews
There are no reviews yet.